SCHEMBL11258729

SCHEMBL11258729

O=C(NC=Cc1ccco1)n1cc(F)c(=O)[nH]c1=O

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 9/20 0.43
▸ MAPT P10636 9/20 0.43
▸ KMT2A Q03164 9/20 0.43
▸ POLB P06746 8/20 0.43
▸ ALDH1A1 P00352 7/20 0.43
▸ SMN1; SMN2 Q16637 4/20 0.43
▸ NPC1 O15118 4/20 0.43
▸ RAB9A P51151 4/20 0.43
▸ CYP3A4 P08684 2/20 0.42
▸ LMNA P02545 1/20 0.42
▸ CYP2D6 P10635 1/20 0.42
▸ MAPK3 P27361 1/20 0.42
▸ ASAH1 Q13510 1/20 0.42
▸ SQOR Q9Y6N5 1/20 0.42
▸ RECQL P46063 4/20 0.42
▸ L3MBTL1 Q9Y468 4/20 0.42
▸ KDM4E B2RXH2 2/20 0.42
▸ TDP1 Q9NUW8 2/20 0.42
▸ ALOX12 P18054 1/20 0.41
▸ NPSR1 Q6W5P4 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11238672 1.00 MEN1 (0.43) MEN1MAPTKMT2APOLBALDH1A1
SCHEMBL11241994 0.78 LMNA (0.43) SMN1; SMN2CYP3A4LMNACYP2D6MAPK3
SCHEMBL11241981 0.75 CYP2D6 (0.43) SMN1; SMN2CYP3A4LMNACYP2D6MAPK3
SCHEMBL11241986 0.75 CYP2D6 (0.43) SMN1; SMN2CYP3A4LMNACYP2D6MAPK3
SCHEMBL11813350 0.75 MAPT (0.43) MEN1MAPTKMT2AALDH1A1SMN1; SMN2
SCHEMBL11395430 0.74 SMN1; SMN2 (0.52) MAPTPOLBALDH1A1SMN1; SMN2CYP3A4
SCHEMBL11279780 0.73 LMNA (0.50) KMT2ASMN1; SMN2CYP3A4LMNACYP2D6
SCHEMBL11279796 0.73 LMNA (0.50) KMT2ASMN1; SMN2CYP3A4LMNACYP2D6
SCHEMBL11460881 0.71 MAPT (0.43) MEN1MAPTKMT2APOLBALDH1A1
SCHEMBL11741360 0.69 LMNA (0.61) KMT2ASMN1; SMN2CYP3A4LMNACYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4349552-A TREATMENT OF CANCER FUJISAWA PHARMACEUTICAL COMPANY, LTD. (JP) 1982-09-14 — — US disclosed
EP-0010941-B1 5-FLUOROURACIL DERIVATIVES, PREPARATION THEREOF AND THEIR PHARMACEUTICAL COMPOSITIONS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1982-05-12 — — EP disclosed
EP-0010941-A1 5-Fluorouracil derivatives, preparation thereof and their pharmaceutical compositions FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1980-05-14 — — EP disclosed
Send feedback